For young people (it seems especially young women) I think the answer could end up going in either direction honestly. I think it's completely reasonable to redirect them to mRNA vaccine until we know more.
Not sure why the J&J vaccine had to pause for older population where clearly the vaccine has a much better benefit/risk profile though. But at least in my area of the US the vaccination rate for senior citizens is quite high already.
Not sure why the J&J vaccine had to pause for older population where clearly the vaccine has a much better benefit/risk profile though. But at least in my area of the US the vaccination rate for senior citizens is quite high already.